ADUSNasdaqServices-Home Health Care ServicesFiscal year ends December 31
Addus HomeCare Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$115.16−0.82 (-0.71%)
Close on Oct 19, 2026
- Market cap
- $2.13B
- P/E (TTM)
- 20.2
- Dividend yield
- –
Margins
Share of revenue, fiscal years 2011 to 2025
Gross margin
32.5%+2.9 pts over 5 years
Operating margin
9.7%+3.9 pts over 5 years
Net margin
6.7%+2.4 pts over 5 years
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +23.2% | +14.4% | +13.2% | +15.5% | |
| Gross profit | +23.2% | +15.5% | +15.3% | +17.6% | |
| Operating income | +35.0% | +26.3% | +25.5% | +24.1% | |
| Net income | +30.3% | +27.7% | +23.7% | +23.5% | |
| EPS, diluted | +23.4% | +22.5% | +20.2% | +17.5% | |
| Free cash flow | -6.0% | +2.3% | +0.2% | +49.2% |
Returns and balance sheet
10 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2016 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | 8.2% | 6.7% | 9.3% | |
| Return on assets | 5.9% | 4.3% | 6.7% | |
| Current ratio | 2.64 | 2.00 | 1.80 | |
| Debt to equity | 0.16 | 0.38 | 0.11 | |
| Net debt to EBITDA | 0.77× | 0.88× | 0.25× | |
| Interest coverage | 6.6× | 14.0× | 10.2× | |
| Capex to revenue | 0.4% | 0.9% | 0.5% | |
| Diluted shares | 11M | 16M | 18M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Addus HomeCare generated $484.79M from operations and spent $36.17M on capital expenditure, dividends and share buybacks. 100% of that went back into the business.
Generated
$484.79M
Used
$36.17M
Capital expenditure$36.17M100%Dividends$00%Share buybacks$00%
DuPont analysis
Return on equity split into margin, efficiency and leverage
Net margin6.7%
×Asset turnover1.00×
×Equity multiplier1.39×
=Return on equity, FY20259.3%
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 6.7% | 1.00× | 1.39× | 9.3% |
| FY2024 | 6.4% | 0.95× | 1.45× | 8.8% |
| FY2023 | 5.9% | 1.08× | 1.46× | 9.3% |
| FY2022 | 4.8% | 1.01× | 1.56× | 7.6% |
| FY2021 | 5.2% | 0.94× | 1.68× | 8.3% |
| FY2020 | 4.3% | 1.00× | 1.54× | 6.7% |
| FY2019 | 3.9% | 1.32× | 1.32× | 6.8% |
| FY2018 | 3.2% | 1.67× | 1.41× | 7.5% |
| FY2017 | 2.8% | 1.70× | 1.54× | 7.4% |
| FY2016 | 3.0% | 1.93× | 1.40× | 8.2% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
5of 9 tests passed in fiscal 2025. Scores of 7 to 9 are usually read as strong.
- ProfitableNet income above zero$95.91M
- Cash generatingOperating cash flow above zero$111.51M
- Return on assets improvedROA up on the prior year7.2% → 6.8%
- Earnings backed by cashOperating cash flow above net income$111.51M vs $95.91M
- Less leverageLong-term debt to assets fell15.5% → 8.4%
- Better liquidityCurrent ratio rose1.67 → 1.80
- No dilutionShare count did not rise17M → 18M
- Gross margin improvedGross margin up on the prior year32.48% → 32.47%
- More efficientAsset turnover rose1.13 → 1.01